The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label study

2017-06-292026-03-272017-06-292005José Artemio Hernández Martínez1471-244Xhttps://doi.org/10.1186/1471-244X-5-22https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1090597/https://repositorio.inprf.gob.mx/handle/123456789/5149engacceso cerradoThe effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label studyarticle5Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz22Inglaterra3